Reaction
Catheter Site Related Reaction reporting signals
As of the last recalculation, Catheter Site Related Reaction appears in 708 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is EPOPROSTENOL (PRR 152.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Epoprostenol | 62 | 152.5 | 153.2 |
| Macitentan | 60 | 27.7 | 27.8 |
| Riociguat | 26 | 24.3 | 24.3 |
| Daptomycin | 7 | 22.5 | 22.5 |
| Sildenafil | 38 | 20.3 | 20.3 |
| Treprostinil | 76 | 19.8 | 19.8 |
| Fosaprepitant Dimeglumine | 9 | 19.5 | 19.5 |
| Sildenafil Powder, | 21 | 17.8 | 17.9 |
| Sildenafil Citrate | 65 | 16.4 | 16.4 |
| Aprepitant | 10 | 16.1 | 16.1 |
| Bosentan | 26 | 15.7 | 15.7 |
| Tadalafil | 46 | 14.4 | 14.4 |
| Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 4 | 13.4 | 13.4 |
| Ambrisentan | 42 | 10.4 | 10.5 |
| Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride | 8 | 7.6 | 7.6 |
| Pegfilgrastim | 20 | 6.1 | 6.1 |